Market Tracker

04/01 5:08am ET

Transition Therapeutics Inc (NASDAQ:TTHI)

6.83
Delayed Data
As of Mar 31
 +0.03 / +0.44%
Today’s Change
4.36
Today|||52-Week Range
8.22
-0.10%
Year-to-Date
No recent news for Transition Therapeutics Inc.

Today’s Trading

Previous close6.80
Today’s open6.96
Day’s range-- - --
Volume8,700
Average volume (3 months)15,367
Market cap$240.1M
Dividend yield--
Data as of 03/31/2015

Growth & Valuation

Earnings growth (last year)-74,855.56%
Earnings growth (this year)-55.94%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratio--
Price/Sales--
Price/Book4.33

Competitors

 Today’s
change
Today’s
% change
QTNTQuotient Ltd+1.00+6.25%
CALACalithera Bioscience...0.000.00%
OXFDOxford Immunotec Glo...+0.81+6.10%
TROVTrovagene Inc-0.19-2.71%
Data as of 03/31/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$0.00
Annual profit (last year)-$20.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Tony F. Cruz
Chief Operating Officer
Carl Damiani
Corporate headquarters
Toronto, Ontario

Forecasts